OUTCOMES OF PATIENTS WITH EXUDATIVE AGE-RELATED MACULAR DEGENERATION TREATED WITH ANTIVASCULAR ENDOTHELIAL GROWTH FACTOR THERAPY FOR THREE OR MORE YEARS
2015 ◽
Vol 31
(6)
◽
pp. 357-362
◽
2009 ◽
Vol 20
(3)
◽
pp. 158-165
◽
2009 ◽
Vol 93
(5)
◽
pp. 622-626
◽
2012 ◽
Vol 21
(4)
◽
pp. 241-247
◽